These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 19768811

  • 1. MDMA-evoked changes in the binding of dopamine D(2) receptor ligands in striatum of rats with unilateral serotonin depletion.
    Ostergaard SD, Alstrup AK, Gramsbergen JB, Minuzzi L, Pedersen K, Jensen SB, Doudet D, Cumming P.
    Synapse; 2010 Jan; 64(1):70-82. PubMed ID: 19768811
    [Abstract] [Full Text] [Related]

  • 2. MDMA-evoked changes in [11C]raclopride and [11C]NMSP binding in living pig brain.
    Rosa-Neto P, Gjedde A, Olsen AK, Jensen SB, Munk OL, Watanabe H, Cumming P.
    Synapse; 2004 Sep 15; 53(4):222-33. PubMed ID: 15266554
    [Abstract] [Full Text] [Related]

  • 3. Age-related changes of dopamine D1-like and D2-like receptor binding in the F344/N rat striatum revealed by positron emission tomography and in vitro receptor autoradiography.
    Suzuki M, Hatano K, Sakiyama Y, Kawasumi Y, Kato T, Ito K.
    Synapse; 2001 Sep 15; 41(4):285-93. PubMed ID: 11494399
    [Abstract] [Full Text] [Related]

  • 4. Positron emission tomography of radioligand binding in porcine striatum in vivo: haloperidol inhibition linked to endogenous ligand release.
    Ishizu K, Smith DF, Bender D, Danielsen E, Hansen SB, Wong DF, Cumming P, Gjedde A.
    Synapse; 2000 Oct 15; 38(1):87-101. PubMed ID: 10941144
    [Abstract] [Full Text] [Related]

  • 5. Comparison of the in vitro receptor binding properties of N-[3H]methylspiperone and [3H]raclopride to rat and human brain membranes.
    Hall H, Wedel I, Halldin C, Kopp J, Farde L.
    J Neurochem; 1990 Dec 15; 55(6):2048-57. PubMed ID: 1977888
    [Abstract] [Full Text] [Related]

  • 6. Enhancement of 3H-N-methylspiperone binding but not 3H-raclopride binding in mouse striatum by MK-801: evidence that factors other than competition by endogenous dopamine are responsible for changes in D2 receptor binding in vivo. Short communication.
    Inoue O, Wakahara S, Kobayashi K, Gee A.
    J Neural Transm (Vienna); 1999 Dec 15; 106(2):131-7. PubMed ID: 10226933
    [Abstract] [Full Text] [Related]

  • 7. Discrepancies in apparent dopamine D2 receptor occupancy between 3H-raclopride and 3H-N-methylspiperone.
    Inoue O, Kobayashi K, Hosoi R, Yamaguchi M, Gee A.
    J Neural Transm (Vienna); 1999 Dec 15; 106(11-12):1099-104. PubMed ID: 10651106
    [Abstract] [Full Text] [Related]

  • 8. Mapping the amphetamine-evoked changes in [11C]raclopride binding in living rat using small animal PET: modulation by MAO-inhibition.
    Pedersen K, Simonsen M, Østergaard SD, Munk OL, Rosa-Neto P, Olsen AK, Jensen SB, Møller A, Cumming P.
    Neuroimage; 2007 Mar 15; 35(1):38-46. PubMed ID: 17223363
    [Abstract] [Full Text] [Related]

  • 9. The influence of different cellular environments on PET radioligand binding: an application to D2/3-dopamine receptor imaging.
    Quelch DR, Withey SL, Nutt DJ, Tyacke RJ, Parker CA.
    Neuropharmacology; 2014 Oct 15; 85(100):305-13. PubMed ID: 24910074
    [Abstract] [Full Text] [Related]

  • 10. Effects of unilateral 6-OHDA lesions on [3H]-N-propylnorapomorphine binding in striatum ex vivo and vulnerability to amphetamine-evoked dopamine release in rat.
    Palner M, Kjaerby C, Knudsen GM, Cumming P.
    Neurochem Int; 2011 Feb 15; 58(3):243-7. PubMed ID: 21163313
    [Abstract] [Full Text] [Related]

  • 11. Positron emission tomography and ex vivo and in vitro autoradiography studies on dopamine D2-like receptor degeneration in the quinolinic acid-lesioned rat striatum: comparison of [11C]raclopride, [11C]nemonapride and [11C]N-methylspiperone.
    Ishiwata K, Ogi N, Hayakawa N, Umegaki H, Nagaoka T, Oda K, Toyama H, Endo K, Tanaka A, Senda M.
    Nucl Med Biol; 2002 Apr 15; 29(3):307-16. PubMed ID: 11929700
    [Abstract] [Full Text] [Related]

  • 12. Effects of rolipram on in vivo dopamine receptor binding.
    Hosoi R, Ishikawa M, Kobayashi K, Gee A, Yamaguchi M, Inoue O.
    J Neural Transm (Vienna); 2002 Sep 15; 109(9):1139-49. PubMed ID: 12203041
    [Abstract] [Full Text] [Related]

  • 13. Dopamine displaces [3H]domperidone from high-affinity sites of the dopamine D2 receptor, but not [3H]raclopride or [3H]spiperone in isotonic medium: Implications for human positron emission tomography.
    Seeman P, Tallerico T, Ko F.
    Synapse; 2003 Sep 15; 49(4):209-15. PubMed ID: 12827639
    [Abstract] [Full Text] [Related]

  • 14. The effect of a 5-HT1A receptor agonist on striatal dopamine release.
    Bantick RA, De Vries MH, Grasby PM.
    Synapse; 2005 Aug 15; 57(2):67-75. PubMed ID: 15906386
    [Abstract] [Full Text] [Related]

  • 15. Quantitative autoradiography of ligands for dopamine receptors and transporters in brain of Göttingen minipig: comparison with results in vivo.
    Minuzzi L, Olsen AK, Bender D, Arnfred S, Grant R, Danielsen EH, Cumming P.
    Synapse; 2006 Mar 15; 59(4):211-9. PubMed ID: 16385509
    [Abstract] [Full Text] [Related]

  • 16. Longitudinal follow-up study of adenoviral vector-mediated gene transfer of dopamine D2 receptors in the striatum in young, middle-aged, and aged rats: a positron emission tomography study.
    Umegaki H, Ishiwata K, Ogawa O, Ingram DK, Roth GS, Oda K, Kurotani S, Kawamura K, Wang WF, Ikari H, Senda M, Iguchi A.
    Neuroscience; 2003 Mar 15; 121(2):479-86. PubMed ID: 14522006
    [Abstract] [Full Text] [Related]

  • 17. Specific binding of [(11)C]raclopride and N-[(3)H]propyl-norapomorphine to dopamine receptors in living mouse striatum: occupancy by endogenous dopamine and guanosine triphosphate-free G protein.
    Cumming P, Wong DF, Gillings N, Hilton J, Scheffel U, Gjedde A.
    J Cereb Blood Flow Metab; 2002 May 15; 22(5):596-604. PubMed ID: 11973432
    [Abstract] [Full Text] [Related]

  • 18. Upregulation of putaminal dopamine D2 receptors in early Parkinson's disease: a comparative PET study with [11C] raclopride and [11C]N-methylspiperone.
    Kaasinen V, Ruottinen HM, Någren K, Lehikoinen P, Oikonen V, Rinne JO.
    J Nucl Med; 2000 Jan 15; 41(1):65-70. PubMed ID: 10647606
    [Abstract] [Full Text] [Related]

  • 19. Deficits in striatal dopamine D(2) receptors and energy metabolism detected by in vivo microPET imaging in a rat model of Huntington's disease.
    Araujo DM, Cherry SR, Tatsukawa KJ, Toyokuni T, Kornblum HI.
    Exp Neurol; 2000 Dec 15; 166(2):287-97. PubMed ID: 11085894
    [Abstract] [Full Text] [Related]

  • 20. Effects of endogenous dopamine on kinetics of [3H]N-methylspiperone and [3H]raclopride binding in the rat brain.
    Young LT, Wong DF, Goldman S, Minkin E, Chen C, Matsumura K, Scheffel U, Wagner HN.
    Synapse; 1991 Nov 15; 9(3):188-94. PubMed ID: 1776131
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.